Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities
Journal of Biochemical Technology · 2026 · 17 (4) · 116-124
DOI: 10.51847/uj649brdma ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical Technology, 2026. Verfasst von Klaus Schmidt und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schmidt, K., Fischer, A., & Müller, D. (2026). Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities. Journal of Biochemical Technology, 17(4), 116-124. https://doi.org/10.51847/uj649brdma
Vancouver
Schmidt K, Fischer A, Müller D. Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities. Journal of Biochemical Technology. 2026;17(4):116-124. doi:10.51847/uj649brdma
BibTeX
@article{Schmidt2026,
author = {Schmidt, Klaus and Fischer, Anna and Müller, Dieter},
title = {Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities},
journal = {Journal of Biochemical Technology},
year = {2026},
volume = {17},
number = {4},
pages = {116--124},
doi = {10.51847/uj649brdma}
}
EUVIMED